Public and investor relations for the innovators in healthcare and technology

We’ve been delivering measurable PR and IR results for innovative companies in health and technology since our founding more than 30 years ago originally as Noonan/Russo Communications.  When it comes to raising awareness of your company and product as well as forging new relationships, no one connects you to the people you want to know like we do. Our team of PhD-level scientists, former journalists, TV producers, and Wall Street professionals is on a first-name basis with the who’s who in media, finance, medicine and technology.

How an Experimental Injection Could Revolutionize HIV Treatment

HIV treatment has come a long way since the early days of the epidemic. Patients can now take various combinations of dozens of medications keep the virus under control and halt their disease from decimating their immune systems and leading to more serious, often fatal outcomes. But harnessing HIV requires daily vigilance. Missing doses of the […]

read more
How free-flowing cash is accelerating small companies’ cancer drug trials
| San Francisco Business Times

As Sutro Biopharma Inc. launched an early-stage clinical trial of an experimental cancer-fighting drug, it started patients at a less-than-effective dose, quickly escalating the amount of the drug it pumps into patients and expanding to a broad range of cancers. The process may sound like a no-brainer, but smaller biotech companies for years were forced to take a […]

read more
More Telehealth Benefits Coming To Medicare Advantage Plans In 2020
| Forbes

Access to telehealth services for seniors got another boost Friday when the Centers for Medicare & Medicaid Services said it would allow private Medicare Advantage plans to offer additional access to virtual doctors in their basic benefit packages.

read more